Winston Kung
2021
In 2021, Winston Kung earned a total compensation of $1.7M as Chief Operating Officer and Chief Financial Officer at PMV Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $225,100 |
|---|---|
| Option Awards | $992,142 |
| Salary | $448,017 |
| Total | $1,665,259 |
Kung received $992.1K in option awards, accounting for 60% of the total pay in 2021.
Kung also received $225.1K in non-equity incentive plan and $448K in salary.
Rankings
In 2021, Winston Kung's compensation ranked 6,797th out of 12,415 executives tracked by ExecPay. In other words, Kung earned more than 45.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,797 out of 12,415 | 45th |
Division Manufacturing | 2,953 out of 5,505 | 46th |
Major group Chemicals And Allied Products | 1,305 out of 2,375 | 45th |
Industry group Drugs | 1,163 out of 2,096 | 45th |
Industry Pharmaceutical Preparations | 849 out of 1,546 | 45th |
Source: SEC filing on April 28, 2023.
Kung's colleagues
We found two more compensation records of executives who worked with Winston Kung at PMV Pharmaceuticals in 2021.